Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1143 | Alvocidib | 0.0316227766017 | 0.9465 | 0.00296 |
| HCC1143 | Alvocidib | 0.1 | 0.7392 | 0.01572 |
| HCC1143 | Alvocidib | 0.1 | 0.6375 | 0.01151 |
| HCC1143 | Alvocidib | 0.1 | 0.7787 | 0.01332 |
| HCC1143 | Alvocidib | 0.316227766017 | 0.1413 | 0.05993 |
| HCC1143 | Alvocidib | 0.316227766017 | 0.2168 | 0.07476 |
| HCC1143 | Alvocidib | 0.316227766017 | 0.1780 | 0.05436 |
| HCC1143 | Alvocidib | 1.0 | -0.2855 | 0.21049 |
| HCC1143 | Alvocidib | 1.0 | -0.2906 | 0.18486 |
| HCC1143 | Alvocidib | 1.0 | -0.3370 | 0.25392 |
| HCC1143 | GSK2334470 | 0.001 | 1.0138 | -0.01050 |
| HCC1143 | GSK2334470 | 0.001 | 1.0920 | 0.00366 |
| HCC1143 | GSK2334470 | 0.001 | 0.9498 | -0.00548 |
| HCC1143 | GSK2334470 | 0.00316227766017 | 0.9198 | 0.00193 |
| HCC1143 | GSK2334470 | 0.00316227766017 | 0.9006 | -0.01102 |
| HCC1143 | GSK2334470 | 0.00316227766017 | 1.0146 | -0.00732 |
| HCC1143 | GSK2334470 | 0.01 | 0.8172 | 0.00594 |
| HCC1143 | GSK2334470 | 0.01 | 0.9618 | -0.00285 |
| HCC1143 | GSK2334470 | 0.01 | 0.9381 | -0.01333 |
| HCC1143 | GSK2334470 | 0.0316227766017 | 1.1000 | 0.00077 |
| HCC1143 | GSK2334470 | 0.0316227766017 | 0.8408 | 0.01002 |
| HCC1143 | GSK2334470 | 0.0316227766017 | 1.0138 | -0.00794 |
| HCC1143 | GSK2334470 | 0.1 | 0.9141 | -0.00026 |
| HCC1143 | GSK2334470 | 0.1 | 0.8883 | 0.00899 |
| HCC1143 | GSK2334470 | 0.1 | 0.9558 | -0.00067 |